Exploring BCL2 regulation and upstream signaling transduction in venetoclax resistance in multiple myeloma: potential avenues for therapeutic intervention
Abstract Investigating venetoclax (VTX) resistance in multiple myeloma (MM) is crucial for the development of novel therapeutic strategies to tackle resistance. We conducted a multi-omic characterization of established VTX-resistant isogenic human myeloma cell lines (HMCL) and primary MM patient sam...
Saved in:
| Main Authors: | Rodrigo Fonseca, Yuan Xiao Zhu, Laura A. Bruins, Joseph Ahmann, Cecilia de Bonolo Campos, Esteban Braggio, Xianfeng Chen, Mariano Arribas, Susie Darvish, Seth Welsh, Erin Meermeier, Kiran K. Mangalaparthi, Richard K. Kandasamy, Greg Ahmann, J. Erin Wiedmeier-Nutor, Akhilesh Pandey, Marta Chesi, P. Leif Bergsagel, Rafael Fonseca |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2025-02-01
|
| Series: | Blood Cancer Journal |
| Online Access: | https://doi.org/10.1038/s41408-025-01215-x |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Venetoclax-based treatment combinations in relapsed/refractory multiple myeloma: practice patterns and impact of secondary cytogenetic abnormalities on outcomes
by: Abiola Bolarinwa, et al.
Published: (2025-04-01) -
Pre-infusion ferritin a predictive biomarker for CAR T-cell therapy in R/R multiple myeloma
by: Eider F. Moreno-Cortes, et al.
Published: (2025-08-01) -
Transductive Architecture
by: Tim Gough
Published: (2022-07-01) -
Venetoclax – The game-changer in hematology
by: Tanmoy Kumar Mandal, et al.
Published: (2020-01-01) -
Outcomes for Patients With Myeloid Neoplasms Treated With Chemotherapy Plus Venetoclax After Prior Venetoclax Therapy
by: Rafael Madero‐Marroquin, et al.
Published: (2025-06-01)